CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models.
Cheung A, Chenoweth AM, Quist J, Sow HS, Malaktou C, Ferro R, Hoffmann RM, Osborn G, Sachouli E, French E, Marlow R, Lacy KE, Papa S, Grigoriadis A, Karagiannis SN.
Cheung A, et al. Among authors: sachouli e.
Cancers (Basel). 2022 Jul 11;14(14):3361. doi: 10.3390/cancers14143361.
Cancers (Basel). 2022.
PMID: 35884422
Free PMC article.